Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Baseline characteristics of women with POI | Women with POI (N = 345) | Women with depressive symptoms (n = 103) | Women without depressive symptoms (n = 242) | P: Vitamin D, nmol/L, mean (SD) | 66.5 (26.6) | 66.5 (51.0-78.0) | 66.0 (51.0-83.0) | 0.46
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We performed a cross-sectional study to identify variables that are associated with depressive symptoms in women with POI using clinician and patient-reported outcome measures (PROM).
Source: Methods.
In short, before the first visit, women were asked to complete multiple PROM questionnaires: Beck Depression Inventory (BDI-II), Greene Climacteric scale (GCS), and in case of grief related to infertility, the Fertility Quality of Life tool (FertiQoL).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Depressive symptoms in women with premature ovarian insufficiency (POI): a cross-sectional observational study
Cross-sectional study · Menopause (New York, N.y.) · 2025
Original publication title
Depressive symptoms in women with premature ovarian insufficiency (POI): a cross-sectional observational study
© 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The Menopause Society.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To explore associations between clinical and patient-reported variables and depressive symptoms in women with premature ovarian insufficiency (POI).
Source: Objective:Abstract: What methods does the paper describe?
An exploratory cross-sectional observational study was conducted using data from the center of expertise for women with POI, Erasmus MC, the Netherlands. To identify variables associated with depressive symptoms, as assessed by patient and clinician-reported outcome measures, we used logistic regression models.
Source: Methods:Abstract: Results
Between April 2020 and December 2023, 345 women with POI were included. In this cohort, the prevalence of depressive symptoms was 29.9%. No significant difference was found in depressive symptoms between women using estrogen plus progestogen therapy (EPT) (41.7%) and those not using EPT (42.6%, P=0.89). Younger age at diagnosis (P=0.01), POI due to a genetic cause (P=0.04), severe menopausal symptoms (P<0.001), and lack of emotional support (P<0.001) were independently associated with depressive symptoms.
The use of EPT or levels of estradiol were not associated with depressive symptoms.
Source: Results:Abstract: Conclusions
The high prevalence of depressive symptoms among women with POI underscores a need for targeted mental health support. Our findings highlight that younger age at diagnosis, severe menopausal symptoms, and fertility-related grief are associated with depression in this population. Given that estradiol levels did not correlate with depressive symptoms, this suggests that psychosocial factors are crucial. Psychological interventions should focus on these factors to address the unique needs of this population.
Source: Conclusions:Authors’ abstract
Objective:
To explore associations between clinical and patient-reported variables and depressive symptoms in women with premature ovarian insufficiency (POI).
Methods:
An exploratory cross-sectional observational study was conducted using data from the center of expertise for women with POI, Erasmus MC, the Netherlands. To identify variables associated with depressive symptoms, as assessed by patient and clinician-reported outcome measures, we used logistic regression models.
Results:
Between April 2020 and December 2023, 345 women with POI were included. In this cohort, the prevalence of depressive symptoms was 29.9%. No significant difference was found in depressive symptoms between women using estrogen plus progestogen therapy (EPT) (41.7%) and those not using EPT (42.6%, P=0.89). Younger age at diagnosis (P=0.01), POI due to a genetic cause (P=0.04), severe menopausal symptoms (P<0.001), and lack of emotional support (P<0.001) were independently associated with depressive symptoms.
The use of EPT or levels of estradiol were not associated with depressive symptoms.
Conclusions:
The high prevalence of depressive symptoms among women with POI underscores a need for targeted mental health support. Our findings highlight that younger age at diagnosis, severe menopausal symptoms, and fertility-related grief are associated with depression in this population. Given that estradiol levels did not correlate with depressive symptoms, this suggests that psychosocial factors are crucial. Psychological interventions should focus on these factors to address the unique needs of this population.
Publication and source details
Original title: Depressive symptoms in women with premature ovarian insufficiency (POI): a cross-sectional observational study
Charissa van Zwol‐Janssens; Yvonne V. Louwers; Joop S.E. Laven; Jits Schipper; Geranne Jiskoot
Menopause (New York, N.y.) · 2025
Address correspondence to: Geranne Jiskoot, PhD, Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Infertility, Erasmus MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands. E-mail: L.jiskoot@erasmusmc.nl © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The Menopause Society.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:28:07.999407+00:00
DOI: 10.1097/gme.0000000000002614 · PMC12688449